(E)-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyl)but-2-en-1-one
(E)-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyl)but-2-en-1-one

(E)-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyl)but-2-en-1-one

FOB
MOQ:
1 g
Shipping:
Express Delivery
Product details
Essential details
MOQ:1 g
Lead time:4 weeks
Shipping:Express Delivery
Product Introduction
A pharmaceutical intermediate specifically developed for the synthesis of active pharmaceutical ingredients (APIs) and key drug intermediates. It offers high purity and structural stability, catering to R&D and industrial applications in medicinal and organic chemistry.